Home

Saba Capital Management, 10% Owner: abrdn Life Sciences Investors HQL Buy · Filed 24/04/26

Trade details

Type
Insider buy
Amount
$1,267,486.26
Shares · price
97,574 sh · $12.99 a share
Held after
2,905,298 sh
Trade date
24/04/25
Filed
24/04/26
Days to filing
1 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+3.5%

abrdn Life Sciences Investors trades, last 26 weeks

What else happened in abrdn Life Sciences Investors around then

Filed or reported within 30 days of the trade day · 24/03/26~24/05/25

Saba Capital Management's recent trades

  • Saba Capital Management

    BuyMexico Fund

    $25.2K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $118.4K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $21.1K

    Filed 10/01

  • Saba Capital Management

    BuyGabelli Healthcare & WellnessRx Trust

    $4,941

    Filed 10/01

  • Saba Capital Management

    SellPimco Dynamic Income Strategy Fund

    $180.9K

    Filed 10/01

Saba Capital Management, 10% Owner — bought $1.3M of abrdn Life Sciences Investors HQL · 97,574 sh @ $12.99 | Whalegun